Joseph Larosa - Apr 7, 2022 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
EVP General Counsel and Secret
Signature
/s/**Joseph LaRosa
Stock symbol
REGN
Transactions as of
Apr 7, 2022
Transactions value $
-$3,687,705
Form type
4
Date filed
4/11/2022, 04:41 PM
Previous filing
Apr 4, 2022
Next filing
Sep 12, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Sale -$3.69M -5.11K -23.23% $721.10 16.9K Apr 7, 2022 Direct F1, F2
holding REGN Common Stock 2.11K Apr 7, 2022 2021 GRAT
holding REGN Common Stock 314 Apr 7, 2022 By 401(k) Plan
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
F2 Represents volume-weighted average price of sales of 5,114 shares of Company stock on April 7, 2022 at prices ranging from $721.10 to $721.13. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 7, 2022 at each separate price.